Trials / Completed
CompletedNCT01132729
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fasting Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Valacyclovir Hydrochlorothiazide Caplet under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valacyclovir Hydrochloride | 1000 mg caplet |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2010-05-28
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01132729. Inclusion in this directory is not an endorsement.